Caption Management, LLC Biogen Inc. Call Options Transaction History

Caption Management, LLC

$6.13 Billion
Q2 2024

Call Options

16 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	BUY	$222.59 - $267.94 $17.1 Million - $20.6 Million	77,000 Added 855.56%	86,000 $22.3 Million
Q3 2023 Nov 14, 2023	SELL	$253.3 - $285.89 $3.55 Million - $4 Million	-14,000 Reduced 60.87%	9,000 $2.31 Million
Q2 2023 Aug 14, 2023	BUY	$275.25 - $318.06 $6.33 Million - $7.32 Million	23,000 New	23,000 $6.55 Million
Q4 2022 Feb 14, 2023	SELL	$252.44 - $306.72 $49.8 Million - $60.5 Million	-197,400 Reduced 48.84%	206,800 $57.3 Million
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $70.7 Million - $97.5 Million	363,000 Added 881.07%	404,200 $108 Million
Q2 2022 Aug 15, 2022	SELL	$187.54 - $223.02 $1.88 Million - $2.23 Million	-10,000 Reduced 19.53%	41,200 $8.4 Million
Q1 2022 May 13, 2022	SELL	$193.77 - $244.14 $24.4 Million - $30.8 Million	-126,100 Reduced 71.12%	51,200 $10.8 Million
Q4 2021 Feb 11, 2022	SELL	$223.92 - $287.77 $7.52 Million - $9.67 Million	-33,600 Reduced 15.93%	177,300 $42.5 Million
Q3 2021 Nov 12, 2021	BUY	$282.99 - $369.05 $6.17 Million - $8.05 Million	21,800 Added 11.53%	210,900 $59.7 Million
Q2 2021 Aug 16, 2021	SELL	$259.0 - $414.71 $29 Million - $46.4 Million	-111,900 Reduced 37.18%	189,100 $65.5 Million
Q1 2021 May 17, 2021	BUY	$242.95 - $284.63 $21.5 Million - $25.2 Million	88,600 Added 41.71%	301,000 $84.2 Million
Q4 2020 Feb 16, 2021	BUY	$236.26 - $355.63 $43.1 Million - $64.9 Million	182,400 Added 608.0%	212,400 $52 Million
Q3 2020 Nov 16, 2020	SELL	$264.77 - $305.71 $5.3 Million - $6.11 Million	-20,000 Reduced 40.0%	30,000 $8.51 Million
Q2 2020 Aug 14, 2020	BUY	$258.66 - $342.55 $12.9 Million - $17.1 Million	50,000 New	50,000 $13.4 Million
Q1 2019 May 14, 2019	SELL	$216.71 - $338.96 $8.67 Million - $13.6 Million	-40,000 Closed	0 $0
Q4 2018 Jan 30, 2019	BUY	$278.5 - $352.75 $11.1 Million - $14.1 Million	40,000 New	40,000 $12 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$2.88 Billion
0.08% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.84 Billion
2.78% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.53 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.1M
Shares

$1.23 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.68M
Shares

$987 Million
0.83% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.

Account